A novel alternative to cytotoxic chemotherapy for gestational trophoblastic disease.

Elias, Kevin M; Braga, Antonio; Horowitz, Neil S; Berkowitz, Ross S

Elias, Kevin M; Braga, Antonio; Horowitz, Neil S; Berkowitz, Ross S.

Afiliación

Elias KM; New England Trophoblastic Disease Centre, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston 02446, MA, USA. Electronic address: kelias@bwh.harvard.edu.
Braga A; Rio de Janeiro Trophoblastic Disease Center, Department of Obstetrics and Gynecology, Rio de Janeiro Federal University, Rio de Janeiro, Brazil; Department of Maternal Child, Fluminense Federal University, Niterói, Brazil.
Horowitz NS; New England Trophoblastic Disease Centre, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston 02446, MA, USA.
Berkowitz RS; New England Trophoblastic Disease Centre, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston 02446, MA, USA.

Lancet Oncol ; 22(11): 1490-1491, 2021 11.

Article en En | MEDLINE | ID: mdl-34624251

Asunto(s)

Enfermedad Trofoblástica Gestacional; Neoplasias Uterinas; Femenino; Enfermedad Trofoblástica Gestacional/tratamiento farmacológico; Humanos; Embarazo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Enfermedad Trofoblástica Gestacional Límite: Female / Humans / Pregnancy Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google